MR编号 | DE/H/4722/001 |
---|
药品名称 | Oxycodon/Naloxon Krka 10 mg/5 mg Retardtabletten |
---|
活性成分 | - Naloxone hydrochloride 5.45 mg
- Oxycodone hydrochloride 10.0 mg
|
---|
剂型 | Prolonged-release tablet |
---|
上市许可持有人 | KRKA d.d. NOVO mesto
Smarjeska cesta 6
SLO-8501 Novo Mesto
Slovenia |
---|
参考成员国 - 产品名称 | Germany (DE) Oxycodon/Naloxon Krka 10 mg/5 mg Retardtabletten |
---|
互认成员国 - 产品名称 | - Denmark (DK)
Oxycodon/Naloxon Krka - Ireland (IE)
- Poland (PL)
Oxynador - Latvia (LV)
Oxynador 10 mg + 5 mg ilgstošās darbības tabletes - Estonia (EE)
NOLDOXEN - Hungary (HU)
OXYNADOR 10 mg/5 mg retard tabletta - Bulgaria (BG)
Adolax 10 mg/ 5 mg prolonged-release tablets - Czechia (CZ)
Adolax 10 mg/5 mg, Tableta s prodlouženým uvolňováním - Slovakia (SK)
Adolax 10 mg/5 mg - Croatia (HR)
Adolax 10 mg/5 mg tablete s produljenim oslobađanjem - Spain (ES)
- Slovenia (SI)
Adolax 10 mg/5 mg tablete s podaljšanim sproščanjem - Romania (RO)
- Lithuania (LT)
Dolnada 10 mg / 5 mg pailginto atpalaidavimo tabletės - Finland (FI)
- Sweden (SE)
- Portugal (PT)
- United Kingdom (Northern Ireland) (XI)
- Belgium (BE)
Oxycodon/Naloxon Krka 10 mg/5 mg tabletten met verlengde afgifte
|
---|
许可日期 | 2017/03/24 |
---|
最近更新日期 | 2024/10/28 |
---|
药物ATC编码 | - N02AA55 oxycodone and naloxone
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|
|
---|